CES1 Carriers in the PAPI Study
NCT03188705
Arterial Occlusive Diseases, Arteriosclerosis
Lancaster, Pennsylvania, United States
View Trial DetailsNCT Number: NCT00005451
To design Computer Aided Telephone Interviewing (CATI) software tools for survey research.
Looking for future studies?
Notify MeUp to 100 year
Male
Observational
BACKGROUND:
CATI (Computer Aided Telephone Interviewing) became a primary means of obtaining quality epidemiological data. Its use steadily increased and in 1995 it was a major technology in use by almost every NIH Institute. Although CATI had been used for many years, its implementation had not kept up with technological developments in computers. Available CATI software products were deficient in features, inflexible, difficult to learn to use and had copious problems. Modern computer technology had the potential to satisfy the growing need for an improved product. This product had applications in over 3000 U.S. companies engaged in public opinion and market research.
DESIGN NARRATIVE:
In Phase I the investigators identified approaches that could be used to develop this software; justified and chose an approach; created requirements and designed specifications for the tool; developed a prototype; and produced a detailed project plan for implementation. In Phase II, the investigators completed and improved the prototype software and tested it in several areas
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
No eligibility criteria
National Heart, Lung, and Blood Institute (NHLBI)
Nih
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03188705
Arterial Occlusive Diseases, Arteriosclerosis
Lancaster, Pennsylvania, United States
View Trial DetailsNCT00241735
Cardiovascular Diseases, Coronary Disease
View Trial DetailsNCT04876963
Arrhythmias, Cardiac, Cardiovascular Diseases
Copenhagen, Denmark
View Trial DetailsNCT06358508
Arterial Occlusive Diseases, Arteriosclerosis
Stanford, California, United States
View Trial Details